Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm
Shunichi Homma(The Neurological Institute), Richard Buchsbaum(Columbia University Irving Medical Center), Conrado J. Estol, John R. Teerlink(University of Glasgow), Piotr Ponikowski(Wroclaw Medical University), John L.P. Thompson(Penn Presbyterian Medical Center), Marco R. Di Tullio(NewYork–Presbyterian Hospital), Gregory Y.H. Lip(Medical University of Białystok), Susan E. Ammon(San Francisco VA Medical Center), J.P. Mohr(The Ohio State University), Andre Gabriel(Columbia University Irving Medical Center), Douglas L. Mann(Washington University in St. Louis), Ronald S. Freudenberger(Lehigh Valley Hospital-Pocono), Bruce Levin(Columbia University), Arthur J. Labovitz(Saint Louis University), Mirna Del Valle(Columbia University Irving Medical Center), Ralph L. Sacco(University of Miami), Patrick M. Pullicino(University of Kent), Vilma Mejia(Columbia University Irving Medical Center), Alexandra Sanford(Columbia University Irving Medical Center), Barry M. Massie(San Francisco VA Medical Center), Stefan D. Anker(Bayer (Germany)), Dirk J. Lok(Deventer Ziekenhuis), Susan Graham(University at Buffalo, State University of New York)
Cited by 580
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
|European Journal of Heart Failure|2016|5.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k